# Halaven

NDC: 43624-002
Generic name: eribulin mesylate
Labeler / Manufacturer: BSP Pharmaceuticals SpA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20170421

FDA application: NDA201532

## Active ingredients

- ERIBULIN MESYLATE: 1 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43624-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43624-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6